Special Key Laboratory of Gene Detection &Therapy of Guizhou Province, Zunyi Medical University, Zunyi Guizhou 563000, China; Department of Immunology, Zunyi Medical University, Zunyi Guizhou 563000, China.
Collaborative Innovation Center of Tissue Damage Repair and Regeneration Medicine of Zunyi Medical University, Zunyi Guizhou 563000, China; Special Key Laboratory of Gene Detection &Therapy of Guizhou Province, Zunyi Medical University, Zunyi Guizhou 563000, China.
Clin Nutr. 2023 Aug;42(8):1521-1530. doi: 10.1016/j.clnu.2023.06.011. Epub 2023 Jun 7.
Alterations in amino acid metabolism is closely related to the occurrence of clinical diseases. The mechanism of tumorigenesis is complex, involving the complicated relationship between tumor cells and immune cells in local tumor microenvironment. A series of recent studies have shown that metabolic remodeling is intimately related to tumorigenesis. And amino acid metabolic reprogramming is one of the important characteristics of tumor metabolic remodeling, which participates in tumor cells growth, survival as well as the immune cell activation and function in the local tumor microenvironment, thereby affecting tumor immune escape. Recent studies have further shown that controlling the intake of specific amino acids can significantly improve the effect of clinical intervention in tumors, suggesting that amino acid metabolism is gradually becoming one of the new promising targets of clinical intervention in tumors. Therefore, developing new intervention strategies based on amino acid metabolism has broad prospects. In this article, we review the abnormal changes in the metabolism of some typical amino acids, including glutamine, serine, glycine, asparagine and so on in tumor cells and summarize the relationship among amino acid metabolism, tumor microenvironment and the function of T cells. In particular, we discuss the current issues that need to be addressed in the related fields of tumor amino acid metabolism, aiming to provide a theoretical basis for the development of new strategies for clinical interventions in tumors based on amino acid metabolism reprogramming.
氨基酸代谢改变与临床疾病的发生密切相关。肿瘤的发生机制复杂,涉及局部肿瘤微环境中肿瘤细胞与免疫细胞之间复杂的关系。一系列的最新研究表明,代谢重编程与肿瘤的发生密切相关。氨基酸代谢重编程是肿瘤代谢重编程的重要特征之一,参与肿瘤细胞的生长、存活以及局部肿瘤微环境中免疫细胞的激活和功能,从而影响肿瘤的免疫逃逸。最近的研究进一步表明,控制特定氨基酸的摄入可以显著提高临床干预肿瘤的效果,提示氨基酸代谢逐渐成为肿瘤临床干预的新的有前途的靶点之一。因此,基于氨基酸代谢开发新的干预策略具有广阔的前景。本文综述了肿瘤细胞中一些典型氨基酸如谷氨酰胺、丝氨酸、甘氨酸、天冬酰胺等代谢的异常变化,并总结了氨基酸代谢、肿瘤微环境与 T 细胞功能之间的关系。特别地,我们讨论了肿瘤氨基酸代谢相关领域需要解决的当前问题,旨在为基于氨基酸代谢重编程的肿瘤临床干预新策略的发展提供理论依据。
Clin Nutr. 2023-8
Biomed Pharmacother. 2022-12
Adv Exp Med Biol. 2017
Cell Commun Signal. 2024-7-29
J Exp Clin Cancer Res. 2023-11-3
Ecotoxicol Environ Saf. 2022-1-1
Cell Commun Signal. 2022-7-27
Cancers (Basel). 2025-7-15
Mol Cancer. 2025-3-11
Front Immunol. 2025-2-14
Front Pharmacol. 2024-12-18
Int J Mol Sci. 2024-11-13